Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

17.80
Delayed Data
As of Aug 28
 +0.28 / +1.60%
Today’s Change
7.31
Today|||52-Week Range
23.30
+114.46%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
AssetsCash94.0M40.3M33.0M36.4M
 
 
 
 
 
Short Term Investment Cash24.8M-8.2M-7.3M3.4M
 
 
 
 
 
Cash & Short Term Investments94.3M88.8M82.2M74.3M
 
 
 
 
 
 
ReceivablesReceivables128.0K675.0K5.5M17.3M
 
 
 
 
 
 
InventoriesInventories0.001.2M7.2M13.4M
 
 
 
 
 
Current AssetsPrepaid Expenses482.0K------
 
 
Other Current Assets0.00983.0K2.1M3.8M
 
 
 
 
Current Assets94.9M91.6M96.9M108.9M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross5.7M6.5M8.1M8.7M
 
 
 
 
 
Depreciation-4.4M-5.1M-5.6M-6.3M
 
 
 
 
 
Intangible Assets912.0K683.0K1.2M225.0K
 
 
 
 
 
Other Assets3.0M971.0K2.8M6.0M
 
 
 
 
 
Total Assets99.2M94.0M111.0M137.5M
 
 
 
 
 
 
LiabilitiesAccounts Payable10.1M2.8M3.1M1.9M
 
 
 
 
 
Short Term Debt6.8M11.8M0.000.00
 
 
 
Accrued Expenses0.005.4M10.2M19.7M
 
 
 
 
Other Current Liabilities370.0K5.9M18.2M19.8M
 
 
 
 
 
Other Liabilities18.8M23.0M26.4M27.5M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt22.7M11.1M34.4M26.9M
 
 
 
 
 
Other Liabilities2.1M1.8M15.3M10.4M
 
 
 
 
 
Total Liabilities44.3M36.4M77.5M66.2M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity54.9M57.6M33.5M71.4M
 
 
 
 
 
Total Shareholder Equity54.9M57.6M33.5M71.4M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding23.9M30.6M40.0M43.0M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.